Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
July, 2026
July 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Michael Makris: Lower Doses of Hemlibra May Still Be Effective
Michael Makris/LinkedIn
Feb 28, 2026, 16:16

Michael Makris: Lower Doses of Hemlibra May Still Be Effective

Michael Makris, Emeritus Professor of Haemostasis and Thrombosis at the University of Sheffield, shared on LinkedIn about his recent commentary, adding:

”The approved dose of Hemlibra (emicizumab) is generous, and smaller doses are likely to be effective.

You can read the arguments in my commentary published in the current issue of the Journal of Thrombosis and Haemostasis.”

Title: Is all the approved emicizumab dose essential?

Authors: Michael Makris

Read the Full Article on JTH

Michael Makris: Lower Doses of Hemlibra May Still Be Effective

Stay updated on all scientific advances with Hemostasis Today.

bleeding disorders Emicizumab Health Hematology Hemlibra Hemophilia Hemostasis Hemostasis News Hemostasis Today Journal of Thrombosis and Haemostasis JTH Medicine Michael Makris thrombosis
NewsFeed